NovaBay Pharmaceuticals, Inc. (NBY) announced Monday an agreement to commercialize BioStem Technologies, Inc.'s (BSEM) Amniotic Tissue Allograft as Avenova Allograft. The company plans to launch Avenova Allograft in the coming weeks.
from RTT - Before the Bell https://ift.tt/iv6eQql
via IFTTT
No comments:
Post a Comment